Literature DB >> 18306312

N-terminal CFTR missense variants severely affect the behavior of the CFTR chloride channel.

G G Gené1, A Llobet, S Larriba, D de Semir, I Martínez, A Escalada, C Solsona, T Casals, J M Aran.   

Abstract

Over 1,500 cystic fibrosis transmembrane conductance regulator (CFTR) gene sequence variations have been identified in patients with cystic fibrosis (CF) and related disorders involving an impaired function of the CFTR chloride channel. However, detailed structure-function analyses have only been established for a few of them. This study aimed evaluating the impact of eight N-terminus CFTR natural missense changes on channel behavior. By site-directed mutagenesis, we generated four CFTR variants in the N-terminal cytoplasmic tail (p.P5L, p.S50P, p.E60K, and p.R75Q) and four in the first transmembrane segment of membrane-spanning domain 1 (p.G85E/V, p.Y89C, and p.E92K). Immunoblot analysis revealed that p.S50P, p.E60K, p.G85E/V, and p.E92K produced only core-glycosylated proteins. Immunofluorescence and whole cell patch-clamp confirmed intracellular retention, thus reflecting a defect of CFTR folding and/or trafficking. In contrast, both p.R75Q and p.Y89C had a glycosylation pattern and a subcellular distribution comparable to the wild-type CFTR, while the percentage of mature p.P5L was considerably reduced, suggesting a major biogenesis flaw on this channel. Nevertheless, whole-cell chloride currents were recorded for all three variants. Single-channel patch-clamp analyses revealed that the channel activity of p.R75Q appeared similar to that of the wild-type CFTR, while both p.P5L and p.Y89C channels displayed abnormal gating. Overall, our results predict a major impact of the CFTR missense variants analyzed, except p.R75Q, on the CF phenotype and highlight the importance of the CFTR N-terminus on channel physiology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18306312     DOI: 10.1002/humu.20721

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  13 in total

1.  Combined bicarbonate conductance-impairing variants in CFTR and SPINK1 variants are associated with chronic pancreatitis in patients without cystic fibrosis.

Authors:  Alexander Schneider; Jessica Larusch; Xiumei Sun; Amy Aloe; Janette Lamb; Robert Hawes; Peter Cotton; Randall E Brand; Michelle A Anderson; Mary E Money; Peter A Banks; Michele D Lewis; John Baillie; Stuart Sherman; James Disario; Frank R Burton; Timothy B Gardner; Stephen T Amann; Andres Gelrud; Ryan George; Matthew J Rockacy; Sirvart Kassabian; Jeremy Martinson; Adam Slivka; Dhiraj Yadav; Nevin Oruc; M Michael Barmada; Raymond Frizzell; David C Whitcomb
Journal:  Gastroenterology       Date:  2010-10-25       Impact factor: 22.682

2.  Biochemical basis of the interaction between cystic fibrosis transmembrane conductance regulator and immunoglobulin-like repeats of filamin.

Authors:  Laura Smith; Richard C Page; Zhen Xu; Ekta Kohli; Paul Litman; Jay C Nix; Sujay S Ithychanda; Jianmin Liu; Jun Qin; Saurav Misra; Carole M Liedtke
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

3.  p.Arg75Gln, a CFTR variant involved in the risk of CFTR-related disorders?

Authors:  Brigitte Martinez; Marion Heller; Natacha Gaitch; Dominique Hubert; Pierre-Regis Burgel; Philippe Levy; Emmanuelle Girodon; Thierry Bienvenu
Journal:  J Hum Genet       Date:  2014-01-23       Impact factor: 3.172

4.  Ubiquitination of disease-causing CFTR variants in a microsome-based assay.

Authors:  Samuel K Estabrooks; Jeffrey L Brodsky
Journal:  Anal Biochem       Date:  2020-07-01       Impact factor: 3.365

Review 5.  Molecular mechanisms of cystic fibrosis - how mutations lead to misfunction and guide therapy.

Authors:  Carlos M Farinha; Isabelle Callebaut
Journal:  Biosci Rep       Date:  2022-07-29       Impact factor: 3.976

6.  Revertant mutants modify, but do not rescue, the gating defect of the cystic fibrosis mutant G551D-CFTR.

Authors:  Zhe Xu; Luísa S Pissarra; Carlos M Farinha; Jia Liu; Zhiwei Cai; Patrick H Thibodeau; Margarida D Amaral; David N Sheppard
Journal:  J Physiol       Date:  2014-03-03       Impact factor: 5.182

Review 7.  Structural mechanisms of CFTR function and dysfunction.

Authors:  Tzyh-Chang Hwang; Jiunn-Tyng Yeh; Jingyao Zhang; Ying-Chun Yu; Han-I Yeh; Samantha Destefano
Journal:  J Gen Physiol       Date:  2018-03-26       Impact factor: 4.086

8.  Deletion of CFTR translation start site reveals functional isoforms of the protein in CF patients.

Authors:  Anabela S Ramalho; Marzena A Lewandowska; Carlos M Farinha; Filipa Mendes; Juan Gonçalves; Celeste Barreto; Ann Harris; Margarida D Amaral
Journal:  Cell Physiol Biochem       Date:  2009-11-04

9.  Analysis of CFTR Gene Variants in Idiopathic Bronchiectasis in Serbian Children.

Authors:  Katarina Milosevic; Aleksandra Nikolic; Aleksandra Divac Rankov; Mila Ljujic; Branimir Nestorovic; Dragica Radojkovic
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2013-06       Impact factor: 1.349

10.  The CFTR P67L variant reveals a key role for N-terminal lasso helices in channel folding, maturation, and pharmacologic rescue.

Authors:  Carleen Mae Sabusap; Disha Joshi; Luba Simhaev; Kathryn E Oliver; Hanoch Senderowitz; Marcel van Willigen; Ineke Braakman; Andras Rab; Eric J Sorscher; Jeong S Hong
Journal:  J Biol Chem       Date:  2021-03-26       Impact factor: 5.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.